Cargando…
Atorvastatin Combined with Low-Dose Dexamethasone Treatment Protects Endothelial Function Impaired by Chronic Subdural Hematoma via the Transcription Factor KLF-2
OBJECTIVE: Our previous study showed that the combination therapy with atorvastatin and low-dose dexamethasone protected endothelial cell function in chronic subdural hematoma (CSDH) injury. In this study, we aimed to investigate the mechanism underlying the effects of this combination therapy on CS...
Autores principales: | Fan, Yueshan, Wang, Dong, Rao, Chenxu, Li, Ying, Rong, Hongtao, Wang, Zengguang, Zhang, Jianning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429211/ https://www.ncbi.nlm.nih.gov/pubmed/32848367 http://dx.doi.org/10.2147/DDDT.S256050 |
Ejemplares similares
-
Atorvastatin combined with dexamethasone promote hematoma absorption in an optimized rat model of chronic subdural hematoma
por: Wang, Dong, et al.
Publicado: (2021) -
Atorvastatin combined with low-dose dexamethasone for vascular endothelial cell dysfunction induced by chronic subdural hematoma
por: Fan, Yue-Shan, et al.
Publicado: (2020) -
Role of Regulatory T cells in Atorvastatin Induced Absorption of Chronic Subdural Hematoma in Rats
por: Quan, Wei, et al.
Publicado: (2019) -
Atorvastatin Plus Low-Dose Dexamethasone May Be Effective for Leukemia-Related Chronic Subdural Hematoma but Not for Leukemia Encephalopathy: A Report of Three Cases
por: Yuan, Jiangyuan, et al.
Publicado: (2021) -
Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma
por: Liu, Hua, et al.
Publicado: (2016)